ArticleBMC public health2026
Endometrial cancer awareness as a public health blind spot: a cross-sectional survey study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndometrial cancer is the most common gynecological cancer. With well-established risk factors and symptoms yet no early-detection screening test, patient-led symptom awareness is essential for early detection. With endometrial cancer rates rising, especially among younger populations, identifying gaps in public knowledge is essential for informing public health strategy. This study evaluates awareness of endometrial cancer symptoms and risk factors among healthy women to identify systemic disparities with global policy implications.
methodsA cross-sectional online survey of Israeli women (n = 1046 participants) was conducted using social media-based recruitment. The questionnaire assessed awareness of endometrial cancer symptoms, risk factors, and intended care-seeking behaviors. Descriptive statistics summarized awareness patterns across demographic cohorts.
resultsDespite high education levels and recent gynecological consultation (> 50% within the past year), only 26.3% of participants reported any awareness of endometrial cancer symptoms. This contrasts sharply with awareness of cervical (98.5%) and ovarian (77.5%) cancers. Most participants (72.6%) failed to recognize abnormal vaginal bleeding as an endometrial cancer warning sign and were unaware of identifiable risk factors (90.0%). While 86% reported they would consult a gynecologist for irregular bleeding, only 1% of the total cohort was classified as “fully aware” of endometrial cancer.
conclusionThe profound deficit in endometrial cancer awareness within this highly educated cohort serves as a warning sign to global public health systems. These findings suggest an “awareness-access” paradox, where clinical access to health care does not equate to health literacy. In the absence of a standardized screening practice, these results from a high-resource population suggest a “high-water mark” indicator: if significant knowledge gaps persist here, they likely signal an even more severe, unmeasured crisis in less-advantaged populations. Policy interventions must rethink strategies to formalize symptom-based education within primary care as a standard of preventative care, to mitigate the rising global burden of endometrial cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.